Treatments for Neuroinflammatory Disorders
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
128
NCT04375436
Safety and Tolerability of NTRX-07 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 10, 2019
Completion: Jun 30, 2020
NCT06194552
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
Start: Sep 6, 2022
Completion: Jun 30, 2023
NCT07058688
A Study of NTRX-07 in Participants With Alzheimer's Disease
Phase: Phase 2
Start: Mar 1, 2025
Completion: Jun 30, 2026
Loading map...